Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Return on Sales (2016 - 2025)

Historic Return on Sales for Agios Pharmaceuticals (AGIO) over the last 14 years, with Q4 2025 value amounting to 5.41%.

  • Agios Pharmaceuticals' Return on Sales rose 35800.0% to 5.41% in Q4 2025 from the same period last year, while for Dec 2025 it was 7.67%, marking a year-over-year decrease of 260400.0%. This contributed to the annual value of 7.64% for FY2025, which is 261000.0% down from last year.
  • Latest data reveals that Agios Pharmaceuticals reported Return on Sales of 5.41% as of Q4 2025, which was up 35800.0% from 8.03% recorded in Q3 2025.
  • Over the past 5 years, Agios Pharmaceuticals' Return on Sales peaked at 105.75% during Q3 2024, and registered a low of 14.71% during Q1 2023.
  • Over the past 5 years, Agios Pharmaceuticals' median Return on Sales value was 8.51% (recorded in 2024), while the average stood at 3.88%.
  • Per our database at Business Quant, Agios Pharmaceuticals' Return on Sales surged by 1180900bps in 2024 and then plummeted by -1137800bps in 2025.
  • Agios Pharmaceuticals' Return on Sales (Quarter) stood at 44.14% in 2021, then crashed by -99bps to 0.4% in 2022, then plummeted by -3490bps to 13.51% in 2023, then soared by 33bps to 9.0% in 2024, then soared by 40bps to 5.41% in 2025.
  • Its last three reported values are 5.41% in Q4 2025, 8.03% for Q3 2025, and 9.04% during Q2 2025.